Article

Michelle Esser Discusses Two Encouraging Breast Cancer Studies

Author(s):

Michelle Esser

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a Chicago gathering of nearly 30,000 oncology professionals in May and June.

Esser was particularly encouraged by discussions surrounding ovarian suppression, surgery and bisphosphonate use in premenopausal women with breast cancer. Esser also mentions a study conducted by Hatem Abdel Azim that looked at genetic differences in breast cancer of young and older women.

Related Videos
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Image of man with grey hair.
Image of man with black hair.
Image of doctor with grey hair.
Image of doctor with black hair.
Related Content
Dr. Regina Hampton illustrates how genomic insights have improved patient outcomes in breast cancer: © stock.adobe.com
March 23rd 2025

Unraveling Disparities and Genomic Advances Across Breast Cancer Care

Ryan Scott
Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of woman with pink ribbon.
March 20th 2025

Evolving Treatments and Advances in HER2-Positive Breast Cancer

Ryan Scott
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of woman with brown hair.
March 20th 2025

A Heaven-Sent Sign About My Brother’s Lymphoma

Laura Yeager
Cancer runs in the family, and after I’d dealt with two breast cancers, my brother came down with lymphoma.
Image of pink ribbon.
March 19th 2025

Gene Expression Testing and Targeted Therapies in Breast Cancer Care

Spencer Feldman
Gene expression testing helps determine chemotherapy needs for HR+ breast cancer, optimizing treatment and reducing unnecessary toxicity.